within Pharmacolibrary.Drugs.ATC.C;

model C09BA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.001,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.1,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C09BA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Quinapril and diuretics (ATC code C09BA06) is a fixed combination antihypertensive medication containing quinapril, an angiotensin-converting enzyme (ACE) inhibitor, and hydrochlorothiazide, a thiazide diuretic. It is used for the treatment of hypertension and heart failure, and remains in clinical use and approved in many countries.</p><h4>Pharmacokinetics</h4><p>No published population pharmacokinetic models were found specifically for the fixed combination quinapril and diuretics (C09BA06). Parameter values are estimated based on publicly available pharmacokinetic data for quinapril and hydrochlorothiazide administered orally in adults.</p><h4>References</h4><ol><li><p>Kaplan, HR, et al., &amp; Andrews, LK (1989). Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology. <i>Angiology</i> 40(4 Pt 2) 335–350. DOI:<a href=\"https://doi.org/10.1177/000331978904000403\">10.1177/000331978904000403</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2539761/\">https://pubmed.ncbi.nlm.nih.gov/2539761</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C09BA06;
